The additional $50 million will go towards venture capital firms that specialize in near- and long-term healthcare solutions for patients in low- and middle-income countries
Krsnaa Diagnostics has commenced its fourth out of eight Diagnostics Center in Ayodhya
Launches Thalassemia Bal Sewa Yojana portal and releases standard treatment guidelines for sickle cell anemia disease
The acquisition of Medisol is part of Lupin's strategy to expand its presence in the EU
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
Pheezee is designed to assess musculoskeletal and neuromuscular health.
Organ Transplants triple across the country; rise from 5000 (2013) to more than 15000 in 2022
The consolidated EBITDA stood at Rs. 89.3 crore in FY23 as compared to Rs. 164.5 crore in the same period last year
Brexit had a negative impact on NHS staff shortages and worsened the workforce crisis
Revenue from operations at Rs 512.81 crores registered a growth of 17% Y-o-Y for full year FY23
Subscribe To Our Newsletter & Stay Updated
